Episode Details

The Pentagon’s new policy to screen all male service members 30 and older for testosterone levels—aimed at keeping troops “on the leading edge of lethality”—is sparking controversy. While low levels may qualify men for hormone therapy, critics are questioning the logic, especially given the government’s past stance that hormone treatment disqualifies transgender service members. A federal judge is demanding answers on this double standard, while medical experts warn that widespread testosterone screening and therapy could harm health, contradicting the goal of readiness. The legal and ethical implications are still unfolding.

Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/d9f6fd92c176c16d